This week our postdoc Mandy Wang attended the Cancer Immunotherapy Conference hosted by the Cancer Research Institute, the European Network for Cancer Immunotherapy, and the American Association for Cancer Research. This conference focused on “Translating Science into Survival.”
Mandy was able to present a poster highlighting her work on “Therapeutic blocking of VEGF binding to neuropilin-2 inhibits PD-L1 to activate anti-tumor immunity in prostate cancer.”
You can find her abstract and all of the other abstracts from the conference here.